ArticleJournal of clinical microbiology1997
Characterization of mycobacterial isolates phylogenetically related to, but different from Mycobacterium simiae.
Article in Journal of clinical microbiology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 52 citations in OpenAlex.
- Article
- Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.Clinical microbiology reviews · 2012Review
- Mycobacterium sherrisii sp. nov., a slow-growing non-chromogenic species.International journal of systematic and evolutionary microbiology · 2011Article
- Mycobacterium lentiflavum in drinking water supplies, Australia.Emerging infectious diseases · 2011Article
- Molecular characterization of a novel fastidious mycobacterium causing lepromatous lesions of the skin, subcutis, cornea, and conjunctiva of cats living in Victoria, Australia.Journal of clinical microbiology · 2008Article
- Isolation of nontuberculous mycobacteria in Zambia: eight case reports.Journal of clinical microbiology · 2005Article
- Mycobacterium lentiflavum, a recently identified slow-growing mycobacterial species: clinical significance in immunosuppressed cancer patients and summary of reported cases of infection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2005Review
- Mycobacterium lentiflavum infection in immunocompetent patient.Emerging infectious diseases · 2005Review
- Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65) for routine identification of Mycobacterium species isolated from clinical sources.Journal of clinical microbiology · 2004Article
- Characterization of a novel group of mycobacteria and proposal of Mycobacterium sherrisii sp. nov.Journal of clinical microbiology · 2004Article
- Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s.Clinical microbiology reviews · 2003Review
- Human infections due to Mycobacterium lentiflavum.Journal of clinical microbiology · 2002Article
- Characterization of a Mycobacterium intracellulare variant strain by molecular techniques.Journal of clinical microbiology · 2001Article
- Burden of unidentifiable mycobacteria in a reference laboratory.Journal of clinical microbiology · 2001Article
- Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species.Clinical microbiology reviews · 2001Review
- Performance assessment of new multiplex probe assay for identification of mycobacteria.Journal of clinical microbiology · 2001Article
- Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays.Journal of clinical microbiology · 1999Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of high-performance liquid chromatography (HPLC) revealed four previously unreported profiles within a group of mycobacteria consisting of 14 clinical isolates. These mycobacteria, whose identification by conventional tests appeared problematic, mostly resembled Mycobacterium avium complex or Mycobacterium simiae. Genetic analysis revealed, within this group, six different nucleic acid sequences in a hypervariable 16S rRNA segment, but all the isolates appeared to be phylogenetically related to M. simiae. Six isolates representing the largest of groups defined by means of genetic sequencing turned out to belong to the newly described species Mycobacterium lentiflavum. Furthermore, three such clusters precisely coincided with three of those defined by HPLC, while the three remaining clusters shared almost identical HPLC profiles. All but one strain (which, although clearly not belonging to the M. avium complex, hybridized with specific commercial DNA probes) showed high-grade resistance to the majority of antimycobacterial drugs. Three of the isolates were clinically significant according to stringent criteria. Sophisticated techniques, like genetic sequencing or HPLC, by now seem indispensable for differentiating unusual and new mycobacteria from well-established ones.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.